12/11
08:07 am
nuvb
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at HC Wainwright from $10.00 to $18.00. They now have a "buy" rating on the stock.
Medium
Report
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at HC Wainwright from $10.00 to $18.00. They now have a "buy" rating on the stock.
12/6
10:40 pm
nuvb
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
Low
Report
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
12/4
01:11 pm
nuvb
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result [Yahoo! Finance]
Low
Report
Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result [Yahoo! Finance]
12/4
12:12 am
nuvb
Lenz Therapeutics: A Close Look [Seeking Alpha]
Low
Report
Lenz Therapeutics: A Close Look [Seeking Alpha]
12/3
11:58 am
nuvb
Nuvation Bio Inc. (NUVB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Medium
Report
Nuvation Bio Inc. (NUVB) Presents at Citi Annual Global Healthcare Conference 2025 Transcript [Seeking Alpha]
12/3
08:00 am
nuvb
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
High
Report
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
12/1
07:20 am
nuvb
Nuvation Bio (NYSE:NUVB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Neutral
Report
Nuvation Bio (NYSE:NUVB) had its "buy" rating reaffirmed by analysts at HC Wainwright.
11/29
04:40 am
nuvb
Nuvation Bio: A Strong Company Now Fairly Priced [Seeking Alpha]
Low
Report
Nuvation Bio: A Strong Company Now Fairly Priced [Seeking Alpha]
11/28
06:44 am
nuvb
Nuvation Bio (NUVB) Halts NUV-1511 and Highlights Safusidenib Data Is Strategic Focus Shifting? [Yahoo! Finance]
Low
Report
Nuvation Bio (NUVB) Halts NUV-1511 and Highlights Safusidenib Data Is Strategic Focus Shifting? [Yahoo! Finance]
11/27
10:35 pm
nuvb
Nuvation Bio (NUVB): Exploring Valuation After a 52% One-Month Rally [Yahoo! Finance]
Low
Report
Nuvation Bio (NUVB): Exploring Valuation After a 52% One-Month Rally [Yahoo! Finance]
11/26
04:05 pm
nuvb
Nuvation Bio to Participate in Upcoming Investor Conferences
Low
Report
Nuvation Bio to Participate in Upcoming Investor Conferences
11/24
10:02 am
nuvb
Nuvation Bio (NYSE:NUVB) was given a new $11.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Nuvation Bio (NYSE:NUVB) was given a new $11.00 price target on by analysts at Truist Financial Corporation.
11/24
08:43 am
nuvb
Nuvation Bio (NYSE:NUVB) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Medium
Report
Nuvation Bio (NYSE:NUVB) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
11/20
10:59 am
nuvb
Nuvation Bio (NYSE:NUVB) was given a new $10.00 price target on by analysts at JMP Securities.
Low
Report
Nuvation Bio (NYSE:NUVB) was given a new $10.00 price target on by analysts at JMP Securities.
11/20
10:58 am
nuvb
Nuvation Bio: Taking Care With Rapid Rises In Valuation (Rating Downgrade) [Seeking Alpha]
Low
Report
Nuvation Bio: Taking Care With Rapid Rises In Valuation (Rating Downgrade) [Seeking Alpha]
11/20
08:54 am
nuvb
Nuvation Bio Surges On Ibtrozi Momentum And B. Riley Buy Rating [Seeking Alpha]
Low
Report
Nuvation Bio Surges On Ibtrozi Momentum And B. Riley Buy Rating [Seeking Alpha]
11/20
08:07 am
nuvb
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at Citizens Jmp from $8.00 to $10.00. They now have a "market outperform" rating on the stock.
Low
Report
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at Citizens Jmp from $8.00 to $10.00. They now have a "market outperform" rating on the stock.
11/20
06:50 am
nuvb
Nuvation Bio (NUVB) Jumps to 3-Year High on Bullish Coverage [Yahoo! Finance]
Low
Report
Nuvation Bio (NUVB) Jumps to 3-Year High on Bullish Coverage [Yahoo! Finance]
11/20
06:02 am
nuvb
Nuvation Bio (NYSE:NUVB) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Low
Report
Nuvation Bio (NYSE:NUVB) was upgraded by analysts at B. Riley to a "strong-buy" rating.
11/19
07:22 am
nuvb
Nuvation Bio (NYSE:NUVB) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
High
Report
Nuvation Bio (NYSE:NUVB) is now covered by analysts at B. Riley. They set a "buy" rating on the stock.
11/18
06:38 am
nuvb
Nuvation Bio Inc. (NUVB) is a Buy at H.C. Wainwright on Cancer Drug Development Progress [Yahoo! Finance]
Low
Report
Nuvation Bio Inc. (NUVB) is a Buy at H.C. Wainwright on Cancer Drug Development Progress [Yahoo! Finance]
11/11
02:52 pm
nuvb
Learn From The Leaders: Jonathan Faison On Using Seeking Alpha For Biotech Investing [Seeking Alpha]
Low
Report
Learn From The Leaders: Jonathan Faison On Using Seeking Alpha For Biotech Investing [Seeking Alpha]
11/8
07:05 pm
nuvb
Is Nuvation Bio (NUVB) One of the Best American Penny Stocks to Buy? [Yahoo! Finance]
Medium
Report
Is Nuvation Bio (NUVB) One of the Best American Penny Stocks to Buy? [Yahoo! Finance]
11/7
05:27 pm
nuvb
Nuvation Bio: Ibtrozi's Rollout So Far Confirms Bullish Case [Seeking Alpha]
Medium
Report
Nuvation Bio: Ibtrozi's Rollout So Far Confirms Bullish Case [Seeking Alpha]
11/4
11:54 am
nuvb
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at Royal Bank Of Canada from $7.00 to $8.00. They now have an "outperform" rating on the stock.
Low
Report
Nuvation Bio (NYSE:NUVB) had its price target raised by analysts at Royal Bank Of Canada from $7.00 to $8.00. They now have an "outperform" rating on the stock.